Project REST: Regulation of Eating and Sleep Topography
Launched by UNIVERSITY OF PITTSBURGH · Aug 13, 2019
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
Project REST is a clinical trial designed to explore how changes in sleep can affect eating habits and weight management in children who are overweight or obese. The researchers believe that not getting enough sleep might lead to eating more food and gaining weight. By studying how sleep impacts children's ability to control their eating and how their brains respond to food, the trial aims to find better ways to help kids manage their weight and sleep better.
To be part of this study, children between the ages of approximately 8 and 12 who are overweight or obese can participate, as long as they are willing to have a short MRI scan, which is a painless imaging test. However, children who usually sleep more than 10 hours a night, have a history of eating disorders, sleep problems, or certain medical conditions, or who are taking medications that affect sleep or appetite won’t be eligible. Participants can expect to learn more about their eating behaviors and the study may lead to new strategies for improving sleep and managing weight in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at risk for obesity (BMI\>=85th percentile for age and sex OR BMI\>=50th percentile for age and sex with at least one obese parent)
- • average time in bed between 9.5-10.5 hours/night
- Exclusion Criteria:
- • previous eating disorder diagnosis and/or sleep or psychiatric conditions
- • conditions affecting executive functioning (e.g., recent concussion, traumatic brain injury)
- • taking medication known to affect sleep/appetite (e.g., antihistamines, stimulants)
- • receiving concurrent treatment for sleep or overweight/obesity
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Providence, Rhode Island, United States
Patients applied
Trial Officials
Andrea B Goldschmidt, Ph.D.
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials